Multiple cutaneous side effects have been reported with the use of immunotherapies including programmed cell death protein 1 inhibitors. We report 2 patients who presented with papillary dermal elastolysis presenting as multiple, skin-colored, wrinkled papules and atrophic macules following an inflammatory eruption in the setting of combination chemotherapy with nivolumab and cabiralizumab. These two cases highlight a novel finding, elastolysis in the setting of chemotherapy with nivolumab and cabiralizumab.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/cup.13492 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pseudoxanthoma elasticum-like papillary dermal elastolysis; A report of two cases and a literature review.
Dermatol Online J
October 2024
Division of Dermatology, Department of Medicine, School of Medicine, The University of Jordan, Amman, Jordan.
Pseudoxanthoma elasticum-like papillary dermal elastolysis is a rare, benign, acquired, gradually-developing chronic elastic tissue disorder that almost exclusively affects post-menopausal women. It is essential to recognize this disease as it mimics the inherited pseudoxanthoma clinically. The pathophysiology behind this disease is multifactorial; it includes intrinsic skin aging, ultraviolet radiation exposure, and genetic components.
View Article and Find Full Text PDFFibroelastolytic papulosis: two cases of disease spectrum variants.
Dermatol Online J
August 2024
Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, New York, USA.
Fibroelastolytic papulosis (FEP) is an acquired cutaneous disorder of elastin that encompasses both white fibrous papulosis of the neck (WFPN) and pseudoxanthoma elasticum (PXE)-like papillary dermal elastolysis (PDE). Although FEP is a benign acquired disorder, it shares overlapping clinical features with pseudoxanthoma elasticum (PXE), a genetic disorder with systemic manifestations. We report two cases of FEP, including the WFPN and PXE-like PDE variants, in elderly women.
View Article and Find Full Text PDFArticle Synopsis
- A 47-year-old woman with several autoimmune and metabolic conditions presented with a painful skin rash characterized by raised, yellow-centered plaques on sun-exposed areas.
- A biopsy revealed specific histopathological features that led to a diagnosis of annular elastolytic giant cell granuloma (AEGCG), a rare inflammatory skin disorder potentially triggered by sunlight exposure.
- The patient showed significant improvement after being treated with ciclosporin, alleviating symptoms like itching and pain, highlighting the challenges in managing AEGCG, which is often resistant to standard treatments.
Extrafacial Acquired Dermal Melanocytosis: An Exceptionally Rare Example With Bilateral Multifocal Disease.
Cureus
May 2024
Dermatopathology, St. Joseph Hospital, Houston, USA.
Dermal melanocytoses are a group of cutaneous disorders characterized by the presence of ectopic melanocytes in the dermis; the most well-known example is the Mongolian spot. Acquired dermal melanocytosis (ADM) is a term used to describe the onset of dermal melanocytosis occurring after its usual age of presentation (i.e.
View Article and Find Full Text PDFBackground: Traditional facelift surgery does not behave well in the correction of nasolabial folds, which is a common clinical problem and needed to be improved.
Objectives: To investigate the effect of free dermal fat grafting during facelift surgery for the treatment of nasolabial folds.
Methods: This prospective cohort study involved 80 patients with moderate to severe nasolabial folds and facial skin dermatolysis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!